SANOFINSESanofi India Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Wed, 29 Oct, 2025 · 13:45 IST

Sanofi India declares Rs 75 interim dividend; quarterly profit declines

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.5%Reaction day
₹4751.00
prior close
₹4746.10
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.5%-1.0% vs market
Pharmaceuticals peers, median of 154sector+0.4%-0.9% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.1
15m
-0.2
30m
-0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.5+0.5-1.0+0.4-0.9
Next day
+1.2+0.3+1.0+0.1+1.1
2d
+0.8-0.1+0.9-0.3+1.1
3d
+0.7+1.0-0.3+0.9-0.2
4d
-0.0+0.2-0.2+0.0-0.0
5d
+0.4-1.5+1.8-1.3+1.7
1w
-3.4-1.5-1.9-2.0-1.4
15d
-3.9-1.7-2.2-2.8-1.1
1m
-8.2-3.1-5.2-2.9-5.4
2m
-14.1-6.6-7.5-5.6-8.5
3m
-14.1-12.3-1.9-11.2-2.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited results and declared an interim dividend of Rs 75 per share, payable within 30 days, with November 7, 2025 as the record date. September-quarter revenue fell to Rs 4,754 crore from Rs 5,240 crore, while profit was Rs 760 crore versus Rs 822 crore. Nine-month continuing profit rose to Rs 2,650 crore from Rs 2,224 crore.

Likely market impact

The dividend supports shareholder returns, but lower quarterly revenue and profit may weigh on sentiment despite higher continuing nine-month profit.